Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6RF9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,724
Award facts
- Contract value 100% obligated
- $41,723.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,723.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania. The order, issued December 1, 2025, with completion by December 2, 2025, represents a competitively awarded, non-set-aside transaction for pharmaceutical supply to support federal medical procurement needs. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Repatha (evolocumab) is a PCSK9 inhibitor used for cardiovascular disease management, and this procurement reflects the Defense Health Agency's ongoing requirement for specialty pharmaceutical inventory. AmerisourceBergen, headquartered in Pennsylvania, maintains one of the largest federal pharmaceutical distribution contracts, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. The company's position as a prime vendor demonstrates its established capability to meet federal procurement requirements through competitive processes and deliver critical medical commodities to support military medical readiness and personnel healthcare.
Quick answers
Who was awarded contract SPE2DR26F6RF9?
SPE2DR26F6RF9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F6RF9 worth?
The government has obligated $41,724 on SPE2DR26F6RF9.
Is contract SPE2DR26F6RF9 an order under another contract?
Yes. SPE2DR26F6RF9 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RF9 competed?
The extent of competition for SPE2DR26F6RF9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award